Eric A. Adams - May 27, 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
President & CEO, Director
Signature
/s/ Eric A Adams
Stock symbol
INM
Transactions as of
May 27, 2024
Transactions value $
$0
Form type
4
Date filed
5/28/2024, 04:26 PM
Previous filing
Feb 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -1.14K -0.7% $0.00 161K May 27, 2024 Common shares 1.14K $263.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00